로딩 중…
지수 로딩 중…
Zenas BioPharma, Inc.
ZBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$19.77+6.38%
2026-06-18
Price Chart
Zenas BioPharma, Inc.+112.30%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.25B |
| Revenue | $0.00 |
| Net Income | $-425M |
| Total Assets | $748M |
| Net Assets | $336M |
| Value | |
| P/B | 3.72x |
| FCF Yield | -16.87% |
| Profitability | |
| ROE | -126.60% |
| ROA | -56.86% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 122.64% |
| Total Debt | $352M |
| FCF | $-210M |
| Cash | $500M |
| Current Ratio | 11.94x |
| Performance | |
| 1Y Return | 112.30% |
| 1M Return | 10.79% |
| From 52W High | -55.68% |
| 1Y MDD | -64.79% |
| Trading | |
| Volume | 1,615,908 shares |
| Trading Value | $31M |
| Per Share | |
| EPS | $-8.12 |
| BPS | $5.21 |